Vimarsana
Biggest News Aggregation in the World

Page 4 - Concomitant Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Concomitant Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Concomitant Use Today - Breaking & Trending Today

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection - Vimarsana News

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

DUBLIN, June 29, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Merck's Noxafil® in the U.S., followi...

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection - Vimarsana News

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18...

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure - Vimarsana News

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence of... | June 15, 2023

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) - Vimarsana News

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin)

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes ...

UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care - Vimarsana News

UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care

21 scientific presentations, including 7 late breakers, showcase the breadth of UCB's portfolio, reinforcing commitment to improving the lives of people living...